K Michaud

Summary

Affiliation: University of Nebraska Medical Center
Country: USA

Publications

  1. ncbi request reprint Impact of total shoulder arthroplasty on generic and shoulder-specific health-related quality-of-life measures: a systematic literature review and meta-analysis
    Michael J Carter
    University of Nebraska Medical Center, 986270 Nebraska Medical Center, Omaha, NE 68198 6270, USA
    J Bone Joint Surg Am 94:e127. 2012
  2. pmc Minocycline and doxycycline therapy in community patients with rheumatoid arthritis: prescribing patterns, patient-level determinants of use, and patient-reported side effects
    Christopher J Smith
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198 6270, USA
    Arthritis Res Ther 13:R168. 2011
  3. pmc Treatment and nontreatment predictors of health assessment questionnaire disability progression in rheumatoid arthritis: a longitudinal study of 18,485 patients
    Kaleb Michaud
    University of Nebraska Medical Center, Omaha, 68198 6270, USA
    Arthritis Care Res (Hoboken) 63:366-72. 2011
  4. pmc Anticitrullinated protein antibody (ACPA) in rheumatoid arthritis: influence of an interaction between HLA-DRB1 shared epitope and a deletion polymorphism in glutathione S-transferase in a cross-sectional study
    Ted R Mikuls
    Omaha Veterans Affairs Medical Center and Nebraska Arthritis Outcomes Research Center, University of Nebraska Medical Center, 986270 Nebraska Medical Center, Omaha, NE 68198 6270, USA
    Arthritis Res Ther 12:R213. 2010
  5. pmc The loss of health status in rheumatoid arthritis and the effect of biologic therapy: a longitudinal observational study
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, 1035 N, Emporia, Suite 288, Wichita, KS 67214, USA
    Arthritis Res Ther 12:R35. 2010
  6. pmc Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases
    Sherine E Gabriel
    Department of Health Sciences Research, Mayo Foundation, Rochester, MN 55905, USA
    Arthritis Res Ther 11:229. 2009
  7. ncbi request reprint Quality of life in patients with rheumatoid arthritis: does abatacept make a difference?
    K Michaud
    Section of Rheumatology and Immunology, University of Nebraska Medical Center, Omaha, NE 68198 6270, USA
    Clin Exp Rheumatol 25:S35-45. 2007
  8. ncbi request reprint Poor to modest agreement between rheumatoid arthritis response measures in clinical practice
    K Michaud
    VA Medical Center and Nebraska Arthritis Outcomes Research Center, University of Nebraska Medical Center, Omaha, Nebraska, USA
    Clin Exp Rheumatol 27:633-40. 2009
  9. doi request reprint Mortality risk by functional status and health-related quality of life in patients with rheumatoid arthritis
    Kaleb Michaud
    University of Nebraska Medical Center, Omaha, Nebraska, USA
    J Rheumatol 39:54-9. 2012
  10. ncbi request reprint Comorbidities in rheumatoid arthritis
    Kaleb Michaud
    University of Nebraska Medical Center, Omaha, Nebraska 68198 6270, USA
    Best Pract Res Clin Rheumatol 21:885-906. 2007

Collaborators

Detail Information

Publications50

  1. ncbi request reprint Impact of total shoulder arthroplasty on generic and shoulder-specific health-related quality-of-life measures: a systematic literature review and meta-analysis
    Michael J Carter
    University of Nebraska Medical Center, 986270 Nebraska Medical Center, Omaha, NE 68198 6270, USA
    J Bone Joint Surg Am 94:e127. 2012
    ..The goal of this systematic review and meta-analysis was to characterize the change in generic and shoulder-specific health-related quality-of-life measures resulting from total shoulder arthroplasty...
  2. pmc Minocycline and doxycycline therapy in community patients with rheumatoid arthritis: prescribing patterns, patient-level determinants of use, and patient-reported side effects
    Christopher J Smith
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198 6270, USA
    Arthritis Res Ther 13:R168. 2011
    ..We characterize the use of minocycline and doxycycline in community-dwelling RA patients by examining associated prescribing patterns, patient-level determinants of use, and side-effect profiles...
  3. pmc Treatment and nontreatment predictors of health assessment questionnaire disability progression in rheumatoid arthritis: a longitudinal study of 18,485 patients
    Kaleb Michaud
    University of Nebraska Medical Center, Omaha, 68198 6270, USA
    Arthritis Care Res (Hoboken) 63:366-72. 2011
    ..To examine predictors of progression of disability in rheumatoid arthritis (RA), as measured by the Health Assessment Questionnaire disability index (HAQ), and to determine rates of progression during biologic treatment...
  4. pmc Anticitrullinated protein antibody (ACPA) in rheumatoid arthritis: influence of an interaction between HLA-DRB1 shared epitope and a deletion polymorphism in glutathione S-transferase in a cross-sectional study
    Ted R Mikuls
    Omaha Veterans Affairs Medical Center and Nebraska Arthritis Outcomes Research Center, University of Nebraska Medical Center, 986270 Nebraska Medical Center, Omaha, NE 68198 6270, USA
    Arthritis Res Ther 12:R213. 2010
    ..The purpose of this study was to examine the associations of GSTM1-null with ACPA positivity in RA and to assess for evidence of interaction between GSTM1 and HLA-DRB1 shared epitope (SE)...
  5. pmc The loss of health status in rheumatoid arthritis and the effect of biologic therapy: a longitudinal observational study
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, 1035 N, Emporia, Suite 288, Wichita, KS 67214, USA
    Arthritis Res Ther 12:R35. 2010
    ..We modeled the progression of loss of health status, and measured incremental costs and effectiveness of biologic therapy in the community...
  6. pmc Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases
    Sherine E Gabriel
    Department of Health Sciences Research, Mayo Foundation, Rochester, MN 55905, USA
    Arthritis Res Ther 11:229. 2009
    ..Taken together, these findings underscore the complexity of the rheumatic diseases and highlight the key role of epidemiological research in understanding these intriguing conditions...
  7. ncbi request reprint Quality of life in patients with rheumatoid arthritis: does abatacept make a difference?
    K Michaud
    Section of Rheumatology and Immunology, University of Nebraska Medical Center, Omaha, NE 68198 6270, USA
    Clin Exp Rheumatol 25:S35-45. 2007
    ..Analysis of these data demonstrates that abatacept therapy has the potential to improve QoL across a range of patients with RA...
  8. ncbi request reprint Poor to modest agreement between rheumatoid arthritis response measures in clinical practice
    K Michaud
    VA Medical Center and Nebraska Arthritis Outcomes Research Center, University of Nebraska Medical Center, Omaha, Nebraska, USA
    Clin Exp Rheumatol 27:633-40. 2009
    ..To evaluate the agreement among several rheumatoid arthritis (RA) response measures in a clinical setting...
  9. doi request reprint Mortality risk by functional status and health-related quality of life in patients with rheumatoid arthritis
    Kaleb Michaud
    University of Nebraska Medical Center, Omaha, Nebraska, USA
    J Rheumatol 39:54-9. 2012
    ....
  10. ncbi request reprint Comorbidities in rheumatoid arthritis
    Kaleb Michaud
    University of Nebraska Medical Center, Omaha, Nebraska 68198 6270, USA
    Best Pract Res Clin Rheumatol 21:885-906. 2007
    ..This chapter reviews important comorbidities in patients with RA, their prevalence, and their relation to RA...
  11. ncbi request reprint Rheumatoid arthritis treatment and the risk of severe interstitial lung disease
    F Wolfe
    National Data Bank for Rheumatic Diseases, Arthritis Research Center Foundation, Wichita, KS 67214, USA
    Scand J Rheumatol 36:172-8. 2007
    ..Reports have suggested that infliximab with or without azathioprine might lead to rapidly progressive or fatal ILD. We used an RA data bank to assess the associations of treatments for RA and severe ILD...
  12. ncbi request reprint Towards an epidemiology of rheumatoid arthritis outcome with respect to treatment: randomized controlled trials overestimate treatment response and effectiveness
    F Wolfe
    National Data Bank for Rheumatic Diseases, Arthritis Research Center Foundation, Wichita, KS 67214, USA
    Rheumatology (Oxford) 44:iv18-iv22. 2005
    ..The consequence of deriving effectiveness estimates from clinical trials is to overestimate the effectiveness and thereby the cost-effectiveness of rheumatoid arthritis treatments...
  13. ncbi request reprint Assessment of pain in rheumatoid arthritis: minimal clinically significant difference, predictors, and the effect of anti-tumor necrosis factor therapy
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, Arthritis Research Center Foundation, Wichita, Kansas 67214, USA
    J Rheumatol 34:1674-83. 2007
    ....
  14. ncbi request reprint Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors
    Eliza F Chakravarty
    Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA
    J Rheumatol 32:2130-5. 2005
    ....
  15. ncbi request reprint The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, Wichita, KS 67214, USA
    Arthritis Rheum 56:1433-9. 2007
    ..This report updates our previous report during 29,314 person-years of followup...
  16. ncbi request reprint Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize ra patients with fibromyalgia
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, Arthritis Research Center Foundation, University of Kansas School of Medicine, Wichita, Kansas 67214, USA
    J Rheumatol 31:695-700. 2004
    ..Little is known about FM among patients with rheumatoid arthritis (RAF). We used the survey definition to characterize persons with RAF and to obtain insight into possible pathogenic mechanisms...
  17. ncbi request reprint Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, Arthritis Research Foundation, Wichita, KS 67214, USA
    Arthritis Rheum 50:1740-51. 2004
    ..Additionally, we sought to determine predictors of lymphoma in RA...
  18. pmc Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study
    Zurab Nadareishvili
    Georgetown University Hospital, Washington, DC, USA
    Arthritis Rheum 59:1090-6. 2008
    ..To determine the risk of stroke in patients with rheumatoid arthritis (RA) and risk factors associated with stroke...
  19. ncbi request reprint The association of rheumatoid arthritis and its treatment with sinus disease
    Kaleb Michaud
    National Data Bank for Rheumatic Diseases, University of Kansas School of Medicine, Wichita, Kansas 67214, USA
    J Rheumatol 33:2412-5. 2006
    ..To determine if rates of sinus disease are increased in patients with rheumatoid arthritis (RA) and whether RA treatment alters the risk of sinus disease...
  20. ncbi request reprint Corticosteroid use in rheumatoid arthritis: prevalence, predictors, correlates, and outcomes
    Liron Caplan
    University of Colorado at Denver and Health Science Center, Denver, USA
    J Rheumatol 34:696-705. 2007
    ....
  21. doi request reprint Biologic drugs for rheumatoid arthritis in the Medicare program: a cost-effectiveness analysis
    Allan J Wailoo
    Health Economics and Decision Science, ScHARR, University of Sheffield, Sheffield, UK
    Arthritis Rheum 58:939-46. 2008
    ..We undertook to develop a model to compare the costs and quality-adjusted life years (QALYs) generated by each of the 4 biologic agents...
  22. ncbi request reprint Resistance of rheumatoid arthritis patients to changing therapy: discordance between disease activity and patients' treatment choices
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, Wichita, Kansas 67214, USA
    Arthritis Rheum 56:2135-42. 2007
    ..This study was undertaken to investigate patients' acceptance and satisfaction with therapy, willingness to change therapy, and reasons for not changing...
  23. ncbi request reprint The effect of low-dose aspirin on the decreased risk of development of dyspepsia and gastrointestinal ulcers associated to cyclooxygenase-2 selective inhibitors
    Elizabeth Benito-Garcia
    Department of Rheumatology, Immunology and Allergy, Brigham and Women s Hospital, Boston, Massachusetts, USA
    J Rheumatol 34:1765-9. 2007
    ....
  24. ncbi request reprint Predicting mortality in patients with rheumatoid arthritis
    Frederick Wolfe
    Arthritis Research Center Foundation and University of Kansas School of Medicine, Wichita, Kansas 67214, USA
    Arthritis Rheum 48:1530-42. 2003
    ..This study was undertaken to evaluate the relative predictive strength and usefulness of a wide range of variables on the risk of mortality in a large, long-term, prospectively studied cohort of patients with RA...
  25. doi request reprint The challenges of determining RA disease activity and remission in clinical practice
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, and University of Kansas School of Medicine, Wichita, KS 67214, USA
    Nat Clin Pract Rheumatol 4:462-3. 2008
  26. ncbi request reprint Minimal disease activity, remission, and the long-term outcomes of rheumatoid arthritis
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, Wichita, Kansas 67214, USA
    Arthritis Rheum 57:935-42. 2007
    ....
  27. ncbi request reprint Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases and University of Kansas School of Medicine, Wichita, KS 67214, USA
    Arthritis Rheum 56:2886-95. 2007
    ..We undertook this study to assess the risk of malignancy among biologic-treated patients in a large US observational database...
  28. ncbi request reprint The prevalence and incidence of work disability in rheumatoid arthritis, and the effect of anti-tumor necrosis factor on work disability
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, 1035 N Emporia, Wichita, KS 67214, USA
    J Rheumatol 34:2211-7. 2007
    ..To determine the prevalence and incidence rates of work disability in rheumatoid arthritis (RA), and to determine the effect of anti-tumor necrosis factor (TNF) therapy on work disability...
  29. ncbi request reprint Sleep disturbance in patients with rheumatoid arthritis: evaluation by medical outcomes study and visual analog sleep scales
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, University of Kansas School of Medicine, Wichita, Kansas 67214, USA
    J Rheumatol 33:1942-51. 2006
    ..SD has taken on new importance with the observation that etanercept and infliximab reduce daytime sleepiness, and patient groups indicate that sleep is an important issue...
  30. ncbi request reprint Preliminary evaluation of a visual analog function scale for use in rheumatoid arthritis
    Frederick Wolfe
    Arthritis Research Center Foundation, University of Kansas School of Medicine, Wichita, KS 67214, USA
    J Rheumatol 32:1261-6. 2005
    ....
  31. ncbi request reprint Work limitations among working persons with rheumatoid arthritis: results, reliability, and validity of the work limitations questionnaire in 836 patients
    Nancy Walker
    Rheumatology Division, Department of Medicine, University of Massachusetts, Worcester, Massachusett, USA
    J Rheumatol 32:1006-12. 2005
    ..To describe workplace limitations and the validity and reliability of the Work Limitations Questionnaire (WLQ) in persons with rheumatoid arthritis (RA)...
  32. ncbi request reprint Expanding the definition of clinical differences: from minimally clinically important differences to really important differences. Analyses in 8931 patients with rheumatoid arthritis
    Frederick Wolfe
    Arthritis Research Center Foundation and the University of Kansas School of Medicine, Wichita, Kansas 67214, USA
    J Rheumatol 32:583-9. 2005
    ..To define RID, we compared mean and/or least desirable clinical states with best and/or most desirable states...
  33. ncbi request reprint Measuring the efficacy and effectiveness of rheumatoid arthritis therapy: time to change our thinking and adopt a new model
    Frederick Wolfe
    J Rheumatol 31:2317-9. 2004
  34. ncbi request reprint Fatigue, rheumatoid arthritis, and anti-tumor necrosis factor therapy: an investigation in 24,831 patients
    Frederick Wolfe
    Arthritis Research Center Foundation, University of Kansas School of Medicine, Wichita, Kansas 67214, USA
    J Rheumatol 31:2115-20. 2004
    ..We evaluate the importance of fatigue in relation to other measures of clinical status, describe predictors of fatigue, and investigate fatigue levels in patients treated with anti-TNF therapy...
  35. ncbi request reprint Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy
    Frederick Wolfe
    Arthritis Research Center Foundation, University of Kansas School of Medicine, Wichita 67214, USA
    Am J Med 116:305-11. 2004
    ..We sought to determine the frequency of heart failure in patients with rheumatoid arthritis, and to determine its predictors, particularly the use of anti-tumor necrosis factor (TNF) therapy...
  36. ncbi request reprint Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, Wichita, Kansas, and University of Kansas School of Medicine, Wichita, Kansas 67214, USA
    Arthritis Rheum 50:372-9. 2004
    ..We undertook this study to determine the baseline rate of TB in RA prior to the introduction of infliximab and to determine the rate of TB among those currently receiving infliximab...
  37. ncbi request reprint Longer use of COX-2-specific inhibitors compared to nonspecific nonsteroidal antiinflammatory drugs: a longitudinal study of 3639 patients in community practice
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases Arthritis Research Center Foundation, Wichita, Kansas 67214, USA
    J Rheumatol 31:355-8. 2004
    ..To compare COX-2-specific inhibitor therapy with conventional nonspecific nonsteroidal antiinflammatory drugs (NS NSAID), and investigate the effect of demographic and disease factors on NSAID duration of use...
  38. ncbi request reprint Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients
    Kaleb Michaud
    Arthritis Research Center Foundation, Wichita, Kansas, USA
    Arthritis Rheum 48:2750-62. 2003
    ..To estimate total direct medical costs in persons with rheumatoid arthritis (RA) and to characterize predictors of these costs...
  39. ncbi request reprint Work disability and its economic effect on 55-64-year-old adults with rheumatoid arthritis
    Saralynn Allaire
    Boston University, Boston, Massachusetts, USA
    Arthritis Rheum 53:603-8. 2005
    ..To examine the extent and financial impact of work disability among older workers with rheumatoid arthritis (RA)...
  40. ncbi request reprint Household income and earnings losses among 6,396 persons with rheumatoid arthritis
    Frederick Wolfe
    Arthritis Research Center Foundation, University of Kansas School of Medicine, Wichita, KS 67214, USA
    J Rheumatol 32:1875-83. 2005
    ..We describe methods for obtaining earnings and household income losses that are applicable to working as well as nonworking RA patients, and we perform such studies using these methods...
  41. ncbi request reprint Can severity be predicted by treatment variables in rheumatoid arthritis administrative data bases?
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, and University of Kansas School of Medicine, Wichita, Kansas 67214, USA
    J Rheumatol 33:1952-6. 2006
    ..We examined whether treatment variables could predict RA severity...
  42. ncbi request reprint Anemia and renal function in patients with rheumatoid arthritis
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, University of Kansas School of Medicine, Wichita, 67214, USA
    J Rheumatol 33:1516-22. 2006
    ..Despite recognition that anemia is common in RA and that renal function may be impaired and affect hemoglobin levels, there are almost no quantitative comparative data regarding the prevalence of anemia or decreased renal function in RA...
  43. ncbi request reprint Extent of occupational hand use among persons with rheumatoid arthritis
    Saralynn Allaire
    Clinical epidemiology Research and Training Unit A203, Boston University School of Medicine, 715 Albany Street, Boston, MA 02118, USA
    Arthritis Rheum 55:294-9. 2006
    ....
  44. ncbi request reprint Gastrointestinal prophylactic therapy among patients with arthritis treated by rheumatology specialists
    Elizabeth Benito Garcia
    Brigham and Women s Hospital, Boston, Massachusetts, USA
    J Rheumatol 33:779-84. 2006
    ..To determine rates of gastroprotective agent (GPA) use among patients with arthritis treated by rheumatologists, and to determine factors associated with GPA prescription...
  45. ncbi request reprint Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases and University of Kansas School of Medicine, Wichita, Kansas 67214, USA
    Arthritis Rheum 54:628-34. 2006
    ..This study was undertaken to determine the rate and predictors of hospitalization for pneumonia and the extent to which specific RA treatments increase pneumonia risk...
  46. ncbi request reprint Jaw pain: its prevalence and meaning in patients with rheumatoid arthritis, osteoarthritis, and fibromyalgia
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, University of Kansas School of Medicine, Wichita, Kansas 67214, USA
    J Rheumatol 32:2421-8. 2005
    ..We investigated the prevalence and correlates of jaw pain, and whether jaw pain is increased in RA, where intrinsic articular disease can be noted radiographically, or is a manifestation of a generalized pain problem...
  47. ncbi request reprint A composite disease activity scale for clinical practice, observational studies, and clinical trials: the patient activity scale (PAS/PAS-II)
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, University of Kansas School of Medicine, Wichita, Kansas 67214, USA
    J Rheumatol 32:2410-5. 2005
    ..To develop and validate a composite patient self-report disease activity scale for use in clinical practice and in observational studies and clinical trials...
  48. ncbi request reprint The disease activity score is not suitable as the sole criterion for initiation and evaluation of anti-tumor necrosis factor therapy in the clinic: discordance between assessment measures and limitations in questionnaire use for regulatory purposes
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, Wichita, Kansas 67214, USA
    Arthritis Rheum 52:3873-9. 2005
    ....
  49. ncbi request reprint Minimal disease activity for rheumatoid arthritis: a preliminary definition
    George A Wells
    Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, Ontario, Canada
    J Rheumatol 32:2016-24. 2005
    ..This set of 2 definitions gained approval of 73% of the attendees. These (and other) definitions will now be subject to further validation in other databases...
  50. ncbi request reprint Toward a definition and method of assessment of treatment failure and treatment effectiveness: the case of leflunomide versus methotrexate
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, Wichita, Kansas, USA
    J Rheumatol 30:1725-32. 2003
    ..In addition, (4) we test the feasibility of performing a clinical trial using a longitudinal data bank...